586199585	586199585	CD	B-NP	O
|	|	NN	I-NP	O
TCH	TCH	NN	I-NP	O
|	|	NN	I-NP	O
42767329	42767329	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5145853	5145853	CD	B-NP	O
|	|	CC	I-NP	O
10/27/2005	10/27/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
osteomyelitis	osteomyelitis	NN	I-NP	I-protein
right	right	JJ	I-NP	I-protein
finger	finger	NN	I-NP	I-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/18/2005	10/18/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/11/2005	1/11/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
DANCEL	DANCEL	NN	I-NP	O
,	,	,	O	O
ELVIS	ELVIS	NNP	B-NP	O
E	E	NNP	I-NP	O
352-37-57-2	352-37-57-2	CD	I-NP	O
Har	Har	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
11/7/05	11/7/05	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
SNF/rehab	SNF/rehab	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
UNTHANK	UNTHANK	NNP	B-NP	O
,	,	,	O	O
JERROLD	JERROLD	NNP	B-NP	O
SEBASTIAN	SEBASTIAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
650	650	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Temperature	Temperature	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
:	:	:	O	O
101	101	CD	B-NP	O
CEFTRIAXONE	CEFTRIAXONE	NN	I-NP	O
2	2	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
MG	MG	NN	I-NP	O
IV	IV	CD	B-NP	O
QD	QD	NN	I-NP	B-DNA
X	X	SYM	B-NP	I-DNA
21	21	CD	I-NP	I-DNA
Days	Day	NNPS	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
March	March	NNP	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
0.25	0.25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QOD	QOD	NN	I-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QOD	QOD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/13/05	7/13/05	CD	B-NP	O
by	by	IN	B-PP	O
WHITTIER	WHITTIER	NNP	B-NP	O
,	,	,	O	O
ROCCO	ROCCO	NNP	B-NP	O
T.	T.	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
GENTAMICIN	GENTAMICIN	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
&	&	CC	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ISORDIL	ISORDIL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
PREDNISONE	PREDNISONE	NN	I-NP	O
2	2	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/23/05	9/23/05	CD	B-NP	O
by	by	IN	B-PP	O
SALEME	SALEME	NNP	B-NP	O
,	,	,	O	O
DARRELL	DARRELL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRIMIDONE	PRIMIDONE	NNP	B-NP	O
&	&	CC	I-NP	O
PREDNISONE	PREDNISONE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
PRIMIDONE	PRIMIDONE	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/23/05	9/23/05	CD	B-NP	O
by	by	IN	B-PP	O
BERLO	BERLO	NN	B-NP	B-protein
,	,	,	O	O
SHERMAN	SHERMAN	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
PREDNISONE	PREDNISONE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
829880886	829880886	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRIMIDONE	PRIMIDONE	NNP	B-NP	O
&	&	CC	I-NP	O
PREDNISONE	PREDNISONE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
VANCOMYCIN	VANCOMYCIN	NN	I-NP	O
HCL	HCL	NN	I-NP	O
1	1	CD	I-NP	O
GM	GM	NNP	I-NP	O
IV	IV	CD	I-NP	O
Q24H	Q24H	NN	I-NP	O
X	X	NN	I-NP	O
21	21	CD	I-NP	O
Days	Days	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
March	March	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
give	give	VBP	B-VP	O
as	as	RB	B-ADVP	O
soon	soon	RB	I-ADVP	O
as	as	IN	B-SBAR	O
pt	pt	NN	B-NP	O
gets	get	VBZ	B-VP	O
to	to	TO	B-PP	O
floor	floor	NN	B-NP	B-protein
NORVASC	NORVASC	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
AMLODIPINE	AMLODIPINE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
90	90	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

LOVENOX	LOVENOX	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
30	30	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
COREG	COREG	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
CARVEDILOL	CARVEDILOL	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	JJR	I-NP	O
90	90	CD	I-NP	O
or	or	CC	I-NP	O
HR	HR	NN	I-NP	O
<	<	SYM	B-NP	O
50	50	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
FLOMAX	FLOMAX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TAMSULOSIN	TAMSULOSIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
70	70	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
17	17	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
qac	qac	NN	B-NP	O
NOVOLOG	NOVOLOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
400	400	CD	I-NP	B-protein
LIPITOR	LIPITOR	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ATORVASTATIN	ATORVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
activity	activity	NN	B-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Uyeno	Uyeno	NNP	I-NP	O
211-747-3406	211-747-3406	CD	I-NP	O
,	,	,	O	O
please	please	NN	B-NP	O
call	call	VBP	B-VP	O
for	for	IN	B-PP	O
appt	appt	NN	B-NP	O
.	.	.	O	O

in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Czapor	Czapor	NNP	I-NP	O
and	and	CC	O	O
Casley	Casley	NNP	B-NP	O
166-567-7672	166-567-7672	CD	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
fever	fever	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
right	right	JJ	I-NP	O
finger	finger	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dm	dm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
afib	afib	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
bph	bph	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
benign	benign	JJ	I-NP	O
prostatic	prostatic	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gerd	gerd	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gastroesophageal	gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hiatal	hiatal	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
hiatal	hiatal	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
djd	djd	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
degenerative	degenerative	JJ	I-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pmr	pmr	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
polymyalgia	polymyalgia	NN	I-NP	O
rheumatica	rheumatica	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
diverticulitis	diverticulitis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diverticulitis	diverticulitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
AAA	AAA	NN	I-NP	O
repair	repair	NN	I-NP	O
1994	1994	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
10	10	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
MRI	MRI	NNP	I-NP	O
right	right	JJ	I-NP	O
hand	hand	NN	I-NP	O
-	-	HYPH	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
osteo	osteo	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
po	po	RB	B-ADVP	O
,	,	,	O	O
lethergy	lethergy	NN	B-NP	O
HPI	HPI	NNP	I-NP	O
:	:	:	O	O
88	88	CD	B-NP	O
M	M	NN	I-NP	O
,	,	,	O	O
nursing	nurse	VBG	B-VP	O
home	home	NN	B-NP	O
resident	resident	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
PMH	PMH	NN	B-NP	O
of	of	IN	B-PP	O
PMR	PMR	NN	B-NP	B-protein
on	on	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
afib	afib	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
not	not	RB	O	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
2/2	2/2	CD	I-NP	O
falls	fall	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
p/w	p/w	NN	I-NP	I-protein
T102	T102	NN	I-NP	I-protein
.4	.4	CD	I-NP	I-protein
,	,	,	O	O
poor	poor	JJ	B-NP	O
po	po	NN	I-NP	O
intake	intake	NN	I-NP	O
and	and	CC	I-NP	O
lethargy	lethargy	NN	I-NP	O
at	at	IN	B-PP	O
NH	NH	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
NH	NH	NN	B-NP	O
for	for	IN	B-PP	O
IV	IV	CD	B-NP	O
Abx	Abx	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
ceftriaxone	ceftriaxone	NN	I-NP	O
x	x	SYM	B-NP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
oxacillin	oxacillin	IN	B-NP	O
4/10/5	4/10/5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
through	through	IN	B-PP	O
PICC	PICC	NN	B-NP	B-protein
for	for	IN	B-PP	O
osteomyelotis	osteomyelotis	NN	B-NP	O
of	of	IN	B-PP	O
R	R	NN	B-NP	B-protein
ring	ring	NN	I-NP	I-protein
finger	finger	NN	I-NP	I-protein
after	after	IN	B-PP	O
debridement	debridement	NN	B-NP	O
at	at	IN	B-PP	O
SFMH	SFMH	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NNP	B-NP	O
VVS	VVS	NNP	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
received	receive	VBD	B-VP	O
1L	1L	NN	B-NP	O
NS	NS	NN	I-NP	O
,	,	,	O	O
UCx	UCx	NNP	B-NP	O
,	,	,	O	O
Bld	Bld	NNP	B-NP	O
Cx	Cx	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
peripheral	peripheral	JJ	I-NP	O
and	and	CC	I-NP	O
Picc	Picc	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
LP	LP	NN	B-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
otherwise	otherwise	RB	I-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

*****	*****	SYM	B-NP	O
PE	PE	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
T98	T98	NN	I-NP	O
.6	.6	CD	I-NP	O
HR78	HR78	NN	I-NP	O
BP136/86	BP136/86	NN	I-NP	O
RR20	RR20	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Gen	Gen	NN	I-NP	O
:	:	:	O	O
elderly	elderly	JJ	B-NP	O
,	,	,	I-NP	O
thin	thin	JJ	I-NP	O
,	,	,	I-NP	O
frail	frail	NN	I-NP	O
,	,	,	O	O
confused	confuse	VBD	B-VP	O
HEENT	HEENT	NNP	B-NP	O
:	:	:	O	O
MM	MM	NN	B-NP	O
dry	dry	NN	I-NP	O
,	,	,	O	O
neck	neck	NN	B-NP	O
supple	supple	NN	I-NP	O
Chest	Chest	NNP	I-NP	O
:	:	:	O	O
CTA	CTA	NN	B-NP	B-protein
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
or	or	CC	I-NP	O
rhonchi	rhonchi	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
3/6	3/6	CD	B-NP	O
HSM	HSM	NN	I-NP	O
at	at	IN	B-PP	O
apex	apex	NN	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	O
flat	flat	JJ	I-NP	O
Abd	Abd	NN	I-NP	O
:	:	:	O	O
NABS	NABS	NNP	B-NP	O
,	,	,	O	O
NT	NT	NNP	B-NP	O
,	,	,	O	O
ND	ND	NNP	B-NP	O
Ext	Ext	NNP	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
e/c/c	e/c/c	NN	I-NP	O
*****	*****	SYM	B-ADJP	O
Data	Data	NNP	B-NP	O
:	:	:	O	O
UA	UA	NNP	B-NP	O
:	:	:	O	O
protein	protein	NN	B-NP	O
+1	+1	NN	I-NP	O
,	,	,	O	O
neg	neg	NN	B-NP	O
LE	LE	NNP	I-NP	O
,	,	,	O	O
neg	neg	NN	B-NP	O
Nit	Nit	NNP	I-NP	O
UCx	UCx	NNP	I-NP	O
:	:	:	O	O
neg	neg	NN	B-NP	O
Bld	Bld	NNP	I-NP	O
Cx	Cx	NNP	I-NP	O
:	:	:	O	O
neg	neg	NN	B-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
afib	afib	NN	B-NP	O
,	,	,	O	O
80	80	CD	B-NP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	O
CXR	CXR	NN	I-NP	O
:	:	:	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
small	small	JJ	B-NP	O
L	L	NN	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
hilar	hilar	JJ	B-NP	O
prominence	prominence	NN	I-NP	O
?	?	.	O	O

pul	pul	NN	B-NP	B-protein
HTN	HTN	NN	I-NP	I-protein
LABS	LABS	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
NA	NA	NN	I-NP	B-cell_type
131	131	CD	I-NP	I-cell_type
WBC	WBC	NNP	I-NP	I-cell_type
:	:	:	O	O
10.8	10.8	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
5.9	5.9	CD	I-NP	O
on	on	IN	B-PP	O
10/28	10/28	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Bands	Band	NNPS	I-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
Alb	Alb	NNP	I-NP	O
:	:	:	O	O
2.7	2.7	CD	B-NP	O
CSF	CSF	NN	I-NP	O
Glucose	Glucose	NN	I-NP	O
:	:	:	O	O
80	80	CD	B-NP	O
CSF	CSF	NN	I-NP	B-protein
Prot	Prot	NNP	I-NP	O
:	:	:	O	O
71.7	71.7	CD	B-NP	O
****	****	SYM	I-NP	O
Hospital	Hospital	NN	I-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
88	88	CD	B-NP	O
yo	yo	NN	I-NP	O
M	M	NN	I-NP	O
with	with	IN	B-PP	O
uncontrolled	uncontrolled	JJ	B-NP	O
DM	DM	NN	I-NP	O
,	,	,	O	O
Hx	Hx	NN	B-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
EF	EF	NN	I-NP	I-protein
30	30	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
malnutrition	malnutrition	NN	B-NP	O
,	,	,	O	O
hyponatremia	hyponatremia	NN	B-NP	O
admitted	admit	VBD	B-VP	O
with	with	IN	B-PP	O
fever	fever	NN	B-NP	O
and	and	CC	I-NP	O
bandemia	bandemia	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
recently	recently	RB	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	B-protein
4th	4th	JJ	I-NP	I-protein
finger	finger	NN	I-NP	I-protein
.	.	.	O	O

Source	Source	NN	B-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
most	most	RBS	B-NP	O
likely	likely	JJ	I-NP	O
osteo	osteo	NN	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
finger	finger	NN	I-NP	O
since	since	IN	B-SBAR	O
pt	pt	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
finish	finish	VB	I-VP	O
4	4	CD	B-NP	O
wks	wk	NNS	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
antibx	antibx	NN	I-NP	O
previously	previously	RB	B-ADVP	O
.	.	.	O	O

Meningitis	Meningitis	NN	B-NP	O
,	,	,	O	O
endocarditis	endocarditis	NN	B-NP	O
,	,	,	O	O
UTI	UTI	NN	B-NP	B-DNA
,	,	,	O	O
and	and	CC	O	O
PNA	PNA	NN	B-NP	B-protein
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

1	1	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

ID	ID	NN	B-NP	O
:	:	:	O	O
fever	fever	NN	B-NP	O
,	,	,	O	O
bandemia	bandemia	NN	B-NP	O
-	-	HYPH	I-NP	O
recent	recent	JJ	I-NP	O
Hx	Hx	NN	I-NP	O
of	of	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
of	of	IN	B-PP	O
R	R	NN	B-NP	B-protein
ringfinger	ringfinger	NN	I-NP	I-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
debridement	debridement	NN	I-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	B-protein
ABx	ABx	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
x-ray	x-ray	NN	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
finger	finger	NN	I-NP	O
here	here	RB	B-ADVP	O
is	be	VBZ	B-VP	O
neg	neg	NN	B-NP	O
for	for	IN	B-PP	O
OM	OM	NN	B-NP	O
.	.	.	O	O

MRI	MRI	NN	B-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
PICC	PICC	NN	B-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
from	from	IN	B-PP	O
recent	recent	JJ	B-NP	O
OM	OM	NN	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

PICC	PICC	NN	B-NP	O
infection	infection	NN	I-NP	O
was	be	VBD	B-VP	O
r/o	r/o	NN	B-NP	O
by	by	IN	B-PP	O
negative	negative	JJ	B-NP	O
PICC	PICC	NN	I-NP	O
cultures	culture	NNS	I-NP	O
;	;	:	O	O
endocarditis	endocarditis	NN	B-NP	O
r/o	r/o	NN	I-NP	O
by	by	IN	B-PP	O
ECHO	ECHO	NN	B-NP	B-protein
.	.	.	O	O

Urine	Urine	NN	B-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

C-diff	C-diff	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
received	receive	VBD	B-VP	O
CTX	CTX	NNP	B-NP	O
,	,	,	O	O
Gent	Gent	NNP	B-NP	O
,	,	,	O	O
Vanco	Vanco	NNP	B-NP	O
initially	initially	RB	B-ADVP	O
and	and	CC	O	O
then	then	RB	O	O
gent	gent	JJ	B-NP	O
d/c	d/c	NN	I-NP	O
'd	'd	VBD	B-VP	O
on	on	IN	B-PP	O
11/25	11/25	CD	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
week	week	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
vanc/ceftriaxone	vanc/ceftriaxone	NN	B-NP	O
for	for	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
.	.	.	O	O

PICC	PICC	NN	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
10/23	10/23	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
delirious	delirious	JJ	B-ADJP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
.	.	.	O	O

A+O	A+O	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Likely	Likely	RB	B-NP	O
toxic	toxic	JJ	I-NP	O
metabolic	metabolic	NN	I-NP	O
.	.	.	O	O

MS	MS	NN	B-NP	O
improved	improve	VBD	B-VP	O
during	during	IN	B-PP	O
hospital	hospital	NN	B-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
uncontrolled	uncontrolled	JJ	B-NP	O
DM	DM	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
lantus	lantus	NN	B-NP	O
and	and	CC	O	O
novolg	novolg	NN	B-NP	O
SS	SS	NN	I-NP	O
.	.	.	O	O

Lantus	Lantus	NN	B-NP	O
inc	inc	NN	I-NP	O
from	from	IN	B-PP	O
64	64	CD	B-NP	O
to	to	TO	B-PP	O
70	70	CD	B-NP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
novolog	novolog	NNP	I-NP	O
17u	17u	NNP	I-NP	O
QAC	QAC	NNP	I-NP	O
.	.	.	O	O

FS	FS	NNS	B-NP	O
120s-190s	120s-190s	CD	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
EF	EF	NN	B-NP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
got	get	VBD	B-VP	O
IVF	IVF	NN	B-NP	B-protein
initially	initially	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
on	on	IN	B-PP	O
1/5	1/5	CD	B-NP	O
new	new	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
so	so	RB	B-NP	O
IVF	IVF	NN	I-NP	B-protein
stopped	stop	VBD	B-VP	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
20mg	20mg	CD	I-NP	O
QOD	QOD	NN	I-NP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
11/25	11/25	CD	B-NP	O
.	.	.	O	O

Not	Not	RB	O	O
on	on	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
for	for	IN	B-PP	O
afib	afib	JJ	B-NP	O
2/2	2/2	CD	I-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
falls	fall	NNS	B-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Malnutrition	Malnutrition	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
seen	see	VBN	B-VP	O
by	by	IN	B-PP	O
nutrition	nutrition	NN	B-NP	O
,	,	,	O	O
recs	rec	NNS	B-NP	O
:	:	:	O	O
MVI	MVI	NN	B-NP	O
,	,	,	O	O
suppl	suppl	NN	B-NP	O
.	.	.	O	O

bid	bid	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ADA	ADA	NN	I-NP	O
restriction	restriction	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Continue	Continue	NN	B-NP	O
IV	IV	CD	I-NP	O
ceftriaxone	ceftriaxone	NN	I-NP	O
and	and	CC	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
for	for	IN	B-PP	O
4	4	CD	B-NP	O
weeks	week	NNS	I-NP	O
total	total	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
4/1/05	4/1/05	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
for	for	IN	B-PP	O
osteomyelitis	osteomyelitis	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	B-protein
4th	4th	JJ	I-NP	I-protein
finger	finger	NN	I-NP	I-protein
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Continue	Continue	IN	B-PP	O
IV	IV	CD	B-NP	O
ceftriaxone	ceftriaxone	NN	I-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
for	for	IN	B-PP	O
4	4	CD	B-NP	O
weeks	week	NNS	I-NP	O
total	total	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
starting	start	VBG	B-VP	O
from	from	IN	B-PP	O
4/1/05	4/1/05	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

PICC	PICC	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
d/c	d/c	NN	B-NP	O
'd	'd	MD	B-VP	O
once	once	RB	B-ADVP	O
antibiotics	antibiotic	NNS	B-NP	O
completed	complete	VBN	B-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
and	and	CC	I-NP	O
occupational	occupational	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
at	at	IN	B-PP	O
rehab	rehab	NN	B-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Come	Come	NNP	B-NP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
fevers	fever	NNS	B-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BARRUS	BARRUS	NNS	B-NP	O
,	,	,	O	O
LEONARDO	LEONARDO	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
PW838	PW838	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
11/7/05	11/7/05	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
02	02	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

